Mukka Proteins Reports Q2 Net Profit of ₹15.99 Crore and Revenue of ₹509 Crore

Market snapshot: Mukka Proteins Limited announced strong Q2 consolidated financial results, with net profit nearly tripling YoY and top-line revenue doubling. The solid financial performance reflects operational scaling across its core fishmeal and fish oil processing business.

Data Snapshot

• Q2 consolidated net profit surged to ₹15.99 crore, representing an increase of ≈172% YoY (derived: ₹15.99 cr vs ₹5.88 cr).
• Q2 consolidated revenue from operations reached ₹509 crore, representing a growth of ≈108% YoY (derived: ₹509 cr vs ₹245 cr).

What's Changed

• Q2 net profit expanded to ₹15.99 crore from ₹5.88 crore in the corresponding period of the previous year.
• Q2 revenue expanded to ₹509 crore from ₹245 crore in the prior-year period.

Key Takeaways

• Net profit grew by ≈172% YoY, demonstrating operating leverage as scale increased.
• Revenue doubled YoY to ₹509 crore, reflecting sustained demand for animal protein and fish meal.
• Commercial momentum is supported by expanding international footprint and regulatory certifications.

SAHI Perspective

Mukka Proteins has demonstrated top-line acceleration and margin resilience in Q2. Strong volume throughput in core animal protein markets and expanding global presence provide visibility on operational scaling.

Market Implications

The significant Q2 earnings growth highlights positive momentum for Mukka Proteins' core market strategy. Continued inventory management efficiency and overseas asset ramp-up will remain vital to preserving cash flows.

Trading Signals

Market Bias: Bullish

Mukka Proteins reported strong Q2 growth, with consolidated revenue doubling to ₹509 crore and net profit expanding to ₹15.99 crore (up ≈172% YoY), demonstrating robust top-line momentum.

Overweight: Animal Feed, Aquaculture Inputs, FMCG / Agriculture

Trigger Factors:

• Ramp-up of commercial output at overseas Oman facility
• Sustained global fishmeal prices
• Working capital and inventory turnover optimization

Time Horizon: Near-term (0-3 months)

Industry Context

The global animal protein and fishmeal sector is benefiting from firm market demand across aquaculture and animal nutrition segments. Mukka Proteins' position as a key manufacturer and exporter enables it to capture industry expansion.

Key Risks to Watch

• Raw material price volatility and seasonal availability of fish catch.
• Working capital intensity associated with inventory holding.
• Foreign currency fluctuations affecting export margins.

Recent Developments

In October 2026, Mukka Proteins received US FDA registration for its processing facilities, announced the commencement of commercial operations at its overseas subsidiary in Oman, and secured a rating outlook revision to Stable from CareEdge Ratings following a ₹47 crore equity warrant issuance.

Closing Insight

Mukka Proteins' Q2 performance reflects sharp operational acceleration, supported by expanding global capacity and key international compliance milestones.

High Performance Trading with SAHI.